Director Eric J. Dale of Bankwell Financial Group, Inc. filed a Form 4 on September 9, 2026, disclosing a purchase of 530 shares of common stock on September 8, 2026, along with a detailed breakdown of restricted stock grants held under the company's stock plan.

Key Highlights

  • Purchase transaction: Eric J. Dale acquired 530 shares of Bankwell Financial Group common stock on September 8, 2026, at a price of $67.11 per share.
  • Indirect ownership: The purchased shares are held indirectly through a Deferred Compensation Plan, bringing that position to 43,026 shares following the transaction.
  • Restricted stock grants: Dale holds shares from four separate restricted stock grants made under the 2022 Bankwell Financial Group, Inc. Stock Plan, dated December 30, 2022; December 29, 2023; February 7, 2025; and February 9, 2026.
  • Latest grant: 1,455 shares were granted on February 9, 2026, with 485 shares scheduled to vest on each of February 7, 2027; February 7, 2028; and February 7, 2029.
  • Reporting person role: Dale is identified as a Director of Bankwell Financial Group, Inc. (NASDAQ:BWFG).

Eric J. Dale's Share Purchase and Restricted Stock Positions at Bankwell Financial Group

According to the filing, Director Eric J. Dale purchased 530 shares of Bankwell Financial Group, Inc. common stock on September 8, 2026, at $67.11 per share. The transaction was coded "P" (purchase) and the shares are held indirectly through a Deferred Compensation Plan. Following the reported transaction, Dale's beneficial ownership in that indirect account stands at 43,026 shares, the filing states.

The Form 4 also discloses four restricted stock grants made to Dale under the 2022 Bankwell Financial Group, Inc. Stock Plan. The earliest grant, made December 30, 2022, consisted of 1,600 shares vesting in four equal annual installments of 25%, with the first installment vesting on January 2, 2024. According to the filing, 1,200 shares from that grant have vested as of the filing date, leaving 400 shares unvested. A second grant of 1,600 shares made December 29, 2023, has a vesting schedule under which 533 shares vested on February 7, 2025, 533 will vest on February 7, 2026, and 534 will vest on February 7, 2027; as of the filing date, 1,066 shares have vested, leaving 534 unvested.

A third grant of 1,800 shares, made February 7, 2025, calls for 600 shares to vest on each of February 7, 2026; February 7, 2027; and February 7, 2028, with 600 shares vested as of the filing date, the filing discloses. The most recent grant of 1,455 shares, made February 9, 2026, has three equal tranches of 485 shares vesting on February 7, 2027; February 7, 2028; and February 7, 2029. The filing also lists separate direct holdings of 37,330 shares. The Form 4 was signed by Angelo G. Fusaro as Attorney-in-Fact for Eric J. Dale on September 9, 2026.

What Was Disclosed

The filing reports a September 8, 2026 open-market purchase of 530 shares at $67.11 by Director Eric J. Dale, held indirectly through a Deferred Compensation Plan, plus the status of four restricted stock grants and direct common stock holdings.